Advertisement

Topics

Novartis Has Blockbuster Targets For Cosentyx In New Autoimmune Indications

17:43 EST 14 Nov 2017 | SCRIP

Next up for Cosentyx is psoriatic arthritis and ankylosing spondylitis. Novartis presented impressive long-term efficacy data at ACR in PsA...

      

Related Stories

 

Original Article: Novartis Has Blockbuster Targets For Cosentyx In New Autoimmune Indications

NEXT ARTICLE

More From BioPortfolio on "Novartis Has Blockbuster Targets For Cosentyx In New Autoimmune Indications"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...